[1]
A. F. Yusupov, “The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration”, Ukr. j. ophthalmol. , no. 3, pp. 28–32, Jul. 2024.